Trends in spinal cord stimulation utilization: change, growth and implications for the future
- 20 April 2023
- journal article
- research article
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 48 (6) , 296-301
Abstract
Chronic pain impacts more than 100 million Americans and has a significant impact on the economy and quality of life. Spinal cord stimulation (SCS) has demonstrated efficacy in managing a growing number of chronic pain conditions. This in combination with an increasing number of physicians trained in SCS placement has produced significant changes in utilization, expense and sites of service related to SCS. In particular, there has been a large increase in SCS placement by non-surgeons, use of percutaneous leads and performance in ambulatory surgery centers instead of inpatient settings. There are also notable differences in SCS use related to age, race, insurance coverage and geography. There is a large potential market and use of these therapies is predicted to grow from $2.41 billion in 2020 to $4.12 billion US dollars globally by 2027. At the same time, there is increasing scrutiny around utilization of this therapy related to cost, complications, long-term efficacy and explant rates that has the potential to impact access to this therapy in the future. We must examine our indications, technique and management to optimize outcomes and utilization of SCS going forward.Keywords
This publication has 27 references indexed in Scilit:
- Retrospective analysis of complications associated with dorsal root ganglion stimulation for pain relief in the FDA MAUDE databaseRegional Anesthesia & Pain Medicine, 2019
- Drivers and Risk Factors of Unplanned 30-Day Readmission Following Spinal Cord Stimulator ImplantationNeuromodulation: Technology at the Neural Interface, 2017
- Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 PatientsNeuromodulation: Technology at the Neural Interface, 2017
- Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trialPain, 2016
- The Volume-Outcome Effect: Impact on Trial-to-Permanent Conversion Rates in Spinal Cord StimulationNeuromodulation: Technology at the Neural Interface, 2016
- Injury and Liability Associated with Implantable Devices for Chronic PainAnesthesiology, 2016
- Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg PainAnesthesiology, 2015
- A National Survey of Spinal Cord Stimulation Trial-to-Permanent Conversion RatesNeuromodulation: Technology at the Neural Interface, 2015
- Spinal Cord Stimulation for Chronic Visceral Abdominal PainPain Medicine, 2010
- Electrical Inhibition of Pain by Stimulation of the Dorsal ColumnsAnesthesia & Analgesia, 1967